NO940084D0 - Fremgangsmaate for behandling av motor-neuron sykdommer ved anvend else av medlemmer av BDNF/NT-3/NGF familien av molekyler - Google Patents
Fremgangsmaate for behandling av motor-neuron sykdommer ved anvend else av medlemmer av BDNF/NT-3/NGF familien av molekylerInfo
- Publication number
- NO940084D0 NO940084D0 NO940084A NO940084A NO940084D0 NO 940084 D0 NO940084 D0 NO 940084D0 NO 940084 A NO940084 A NO 940084A NO 940084 A NO940084 A NO 940084A NO 940084 D0 NO940084 D0 NO 940084D0
- Authority
- NO
- Norway
- Prior art keywords
- bdnf
- treatment
- molecules
- motor
- members
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Water Treatments (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Water Treatment By Sorption (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72770491A | 1991-07-10 | 1991-07-10 | |
PCT/US1992/004228 WO1993001300A1 (en) | 1991-07-10 | 1992-05-19 | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940084D0 true NO940084D0 (no) | 1994-01-10 |
NO940084L NO940084L (no) | 1994-03-08 |
Family
ID=24923677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940084A NO940084L (no) | 1991-07-10 | 1994-01-10 | Fremgangsmåte for behandling av motor-neuron sykdommer ved anvendelse av medlemmer av BDNF/NT-3/NGF familien av molekyler |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP0593516B1 (no) |
JP (1) | JPH06509094A (no) |
CN (1) | CN1065768C (no) |
AT (1) | ATE202939T1 (no) |
AU (2) | AU675409B2 (no) |
CA (1) | CA2113083A1 (no) |
DE (1) | DE69231930T2 (no) |
DK (1) | DK0593516T3 (no) |
ES (1) | ES2157903T3 (no) |
FI (1) | FI940098A (no) |
GR (1) | GR3036776T3 (no) |
HU (1) | HUT70275A (no) |
IE (1) | IE921602A1 (no) |
IL (1) | IL101928A0 (no) |
NO (1) | NO940084L (no) |
PT (1) | PT100501A (no) |
RU (1) | RU94016525A (no) |
SK (1) | SK2694A3 (no) |
WO (1) | WO1993001300A1 (no) |
ZA (1) | ZA923639B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025684A1 (en) * | 1992-06-12 | 1993-12-23 | Regeneron Pharmaceuticals, Inc. | Therapeutic and diagnostic methods based on neurotrophin-4 expression |
FR2717496B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
CA2408255A1 (en) | 2000-05-05 | 2001-11-15 | Marie T. Filbin | Methods for stimulating nervous system regeneration and repair by regulating arginase 1 and polyamine synthesis |
RU2434636C2 (ru) * | 2004-11-17 | 2011-11-27 | Ньюралстем, Инк. | Трансплантация нервных клеток для лечения нейродегенеративных состояний |
WO2008156418A1 (en) * | 2007-06-19 | 2008-12-24 | Astrazeneca Ab | A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
MX2010001395A (es) * | 2007-08-10 | 2010-03-10 | Regeneron Pharma | Anticuerpos humanos de alta afinidad de factor de crecimiento de nervio humano. |
WO2014111525A2 (en) | 2013-01-18 | 2014-07-24 | Anaxomics Biotech, Sl | New combination therapies for treating nervous system diseases |
US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
WO2023164311A2 (en) * | 2022-02-28 | 2023-08-31 | Bioincept, Llc | Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923696A (en) * | 1987-05-04 | 1990-05-08 | Baylor College Of Medicine | Method to prepare a neurotrophic composition |
GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
IE903130A1 (en) * | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
-
1992
- 1992-05-19 CA CA2113083A patent/CA2113083A1/en not_active Abandoned
- 1992-05-19 SK SK26-94A patent/SK2694A3/sk unknown
- 1992-05-19 DE DE69231930T patent/DE69231930T2/de not_active Expired - Lifetime
- 1992-05-19 RU RU94016525/14A patent/RU94016525A/ru unknown
- 1992-05-19 AT AT92912453T patent/ATE202939T1/de not_active IP Right Cessation
- 1992-05-19 EP EP92912453A patent/EP0593516B1/en not_active Expired - Lifetime
- 1992-05-19 PT PT100501A patent/PT100501A/pt not_active Application Discontinuation
- 1992-05-19 CN CN92105070A patent/CN1065768C/zh not_active Expired - Fee Related
- 1992-05-19 AU AU20095/92A patent/AU675409B2/en not_active Ceased
- 1992-05-19 JP JP5502202A patent/JPH06509094A/ja active Pending
- 1992-05-19 ES ES92912453T patent/ES2157903T3/es not_active Expired - Lifetime
- 1992-05-19 EP EP96111711A patent/EP0755682A1/en not_active Withdrawn
- 1992-05-19 DK DK92912453T patent/DK0593516T3/da active
- 1992-05-19 IL IL101928A patent/IL101928A0/xx unknown
- 1992-05-19 HU HU9400063A patent/HUT70275A/hu unknown
- 1992-05-19 ZA ZA923639A patent/ZA923639B/xx unknown
- 1992-05-19 WO PCT/US1992/004228 patent/WO1993001300A1/en active IP Right Grant
- 1992-07-01 IE IE160292A patent/IE921602A1/en not_active Application Discontinuation
-
1994
- 1994-01-10 FI FI940098A patent/FI940098A/fi not_active Application Discontinuation
- 1994-01-10 NO NO940084A patent/NO940084L/no unknown
-
1996
- 1996-11-08 AU AU70676/96A patent/AU7067696A/en not_active Abandoned
-
2001
- 2001-10-03 GR GR20010401637T patent/GR3036776T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0593516B1 (en) | 2001-07-11 |
DE69231930T2 (de) | 2002-04-11 |
GR3036776T3 (en) | 2002-01-31 |
FI940098A (fi) | 1994-03-10 |
CN1065768C (zh) | 2001-05-16 |
RU94016525A (ru) | 1996-06-10 |
FI940098A0 (fi) | 1994-01-10 |
DE69231930D1 (de) | 2001-08-16 |
PT100501A (pt) | 1993-09-30 |
IL101928A0 (en) | 1992-12-30 |
CN1071585A (zh) | 1993-05-05 |
ATE202939T1 (de) | 2001-07-15 |
NO940084L (no) | 1994-03-08 |
SK2694A3 (en) | 1995-02-08 |
EP0755682A1 (en) | 1997-01-29 |
IE921602A1 (en) | 1993-01-13 |
ZA923639B (en) | 1993-02-24 |
WO1993001300A1 (en) | 1993-01-21 |
ES2157903T3 (es) | 2001-09-01 |
DK0593516T3 (da) | 2001-09-17 |
AU2009592A (en) | 1993-02-11 |
JPH06509094A (ja) | 1994-10-13 |
EP0593516A4 (en) | 1995-01-18 |
EP0593516A1 (en) | 1994-04-27 |
HUT70275A (en) | 1995-09-28 |
AU7067696A (en) | 1997-01-16 |
CA2113083A1 (en) | 1993-01-21 |
HU9400063D0 (en) | 1994-06-28 |
AU675409B2 (en) | 1997-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940084D0 (no) | Fremgangsmaate for behandling av motor-neuron sykdommer ved anvend else av medlemmer av BDNF/NT-3/NGF familien av molekyler | |
Gatz et al. | Psychological interventions with older adults. | |
NO951592L (no) | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system | |
DE69131514T2 (de) | Herstellung von biologisch aktiven rekombinanten Mitgliedern der NGF/BDNF-Familie neurotroper Proteine | |
ATE238060T1 (de) | Verwendung von eisenbindenden polymeren zur herstellung eines medikaments zur oralen verabreichung | |
AU2282395A (en) | Nitric oxide donor composition and method for treatment of anal disorders | |
NO883896D0 (no) | Konjugater av cytokiner med immunglobuliner. | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE69203254D1 (de) | Herstellung von Crackkatalysatoren und Crackverfahren mit diesen. | |
FI943028A0 (fi) | Happoa kestävä FGF-koostumus ja menetelmä ruoansulatuskanavassa esiintyvien, haavaumia aiheuttavien sairauksien hoitamiseksi | |
DE3782346D1 (de) | Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln. | |
DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
DK36889D0 (da) | Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af kognitive lidelser | |
Avery et al. | Bright dawn simulation compared with bright morning light in the treatment of winter depression | |
ES2152479T3 (es) | Uso de preparaciones de inmunoglobulinas para la fabricacion de un medicamento de administracion oral para el tratamiento y la profilaxis de estados de dolor cronico. | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
Gordon | The relationship between language and behaviour. | |
MD1716B2 (en) | Use of melatonin for treatment of patients dependent on benzodiazepine | |
KR880009661A (ko) | 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도 | |
Metter et al. | Theoretical, Clinical, Research, and Ethical Constraints of the Eye Movement Desensitization Reprocessing Technique. | |
Sweeney et al. | Healing a child's spirit through play therapy: A scriptural approach to treating children. | |
Aurela | A systematic storytelling therapy. | |
RU2214215C2 (ru) | Устройство для воздействия на человека и способ терапевтического воздействия | |
Hoogduin et al. | Double-Blind Research Psychotherapy | |
Le Huche | Fundmental malfunctions of stuttering: A theoretical model. Therapeutic applications |